{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:45:18Z","timestamp":1794606318966,"version":"4.9.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273958"],"award-info":[{"award-number":["82273958"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515011452"],"award-info":[{"award-number":["2024A1515011452"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515012521"],"award-info":[{"award-number":["2023A1515012521"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010883","name":"Traditional Chinese Medicine Bureau of Guangdong Province","doi-asserted-by":"publisher","award":["20231079"],"award-info":[{"award-number":["20231079"]}],"id":[{"id":"10.13039\/501100010883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Brain metastases represent a significant cause of morbidity and mortality in non-small cell lung cancer (NSCLC), with limited therapeutic options. The unique brain microenvironment, characterized by low lipid availability, may drive NSCLC cells to adapt through lipid metabolic reprogramming. In this study, we identify a novel mechanism by which IGF2BP3-driven lipid metabolism promotes the brain colonization of NSCLC cells through the IGF2BP3-FASN axis. Elevated IGF2BP3 expression in NSCLC brain metastases correlates with poor prognosis and promotes cancer cell migration, invasion, and brain colonization by activating the lipogenesis pathway. We further identified that FASN was a downstream target of IGF2BP3 in NSCLC cells. Mechanistically, IGF2BP3 binds to FASN mRNA, enhancing its stability through RNA-binding activity. FASN is essential for neutral lipid accumulation and brain colonization, as demonstrated in vitro and in vivo. Our findings highlight the critical role of IGF2BP3 in lipid metabolism and propose that targeting IGF2BP3 may provide a promising therapeutic strategy for NSCLC brain colonization.<\/jats:p>","DOI":"10.1038\/s41419-025-08006-z","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:20:50Z","timestamp":1759731650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The IGF2BP3\u2013FASN axis drives lipid metabolic reprogramming to promote brain colonization in non-small cell lung cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Jingwei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianshan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxue","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7861-1560","authenticated-orcid":false,"given":"Libin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peibin","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangchao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7320-5135","authenticated-orcid":false,"given":"Yandong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2395-2453","authenticated-orcid":false,"given":"Xiaolei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"8006_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"8006_CR2","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM. Ann Surg Oncol. 2010;17:1471\u20134.","journal-title":"Ann Surg Oncol"},{"key":"8006_CR3","doi-asserted-by":"publisher","first-page":"S2168","DOI":"10.21037\/jtd.2018.06.68","volume":"10","author":"JJAO Schoenmaekers","year":"2018","unstructured":"Schoenmaekers JJAO, Dingemans A-MC, Hendriks LEL. Brain imaging in early stage non-small cell lung cancer: still a controversial topic?. J Thorac Dis. 2018;10:S2168\u2013S71.","journal-title":"J Thorac Dis"},{"key":"8006_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1200\/JOP.19.00357","volume":"15","author":"V Ernani","year":"2019","unstructured":"Ernani V, Stinchcombe TE. Management of brain metastases in non-small-cell lung cancer. J Oncol Pract. 2019;15:563\u201370.","journal-title":"J Oncol Pract"},{"key":"8006_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10549-020-05552-2","volume":"180","author":"MN Mills","year":"2020","unstructured":"Mills MN, Figura NB, Arrington JA, Yu H-HM, Etame AB, Vogelbaum MA, et al. Management of brain metastases in breast cancer: a review of current practices and emerging treatments. Breast Cancer Res Treat. 2020;180:279\u2013300.","journal-title":"Breast Cancer Res Treat"},{"key":"8006_CR6","doi-asserted-by":"crossref","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368:eaaw5473.","DOI":"10.1126\/science.aaw5473"},{"key":"8006_CR7","doi-asserted-by":"crossref","unstructured":"Haddad-Tovolli R, Dragano NRV, Ramalho AFS, Velloso LA. Development and function of the blood-brain barrier in the context of metabolic control. Front Neurosci. 2017;11:224.","DOI":"10.3389\/fnins.2017.00224"},{"key":"8006_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1471-4159.1977.tb09621.x","volume":"29","author":"EH McGale","year":"1977","unstructured":"McGale EH, Pye IF, Stonier C, Hutchinson EC, Aber GM. Studies of the inter-relationship between cerebrospinal fluid and plasma amino acid concentrations in normal individuals. J Neurochem. 1977;29:291\u20137.","journal-title":"J Neurochem"},{"key":"8006_CR9","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1158\/2159-8290.CD-19-1228","volume":"10","author":"B Ngo","year":"2020","unstructured":"Ngo B, Kim E, Osorio-Vasquez V, Doll S, Bustraan S, Liang RJ, et al. Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition. Cancer Discov. 2020;10:1352\u201373.","journal-title":"Cancer Discov"},{"key":"8006_CR10","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/nrc.2016.89","volume":"16","author":"RoehrigF Schulze","year":"2016","unstructured":"Schulze RoehrigF. A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer. 2016;16:732\u201349.","journal-title":"Nat Rev Cancer"},{"key":"8006_CR11","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1016\/j.bmcl.2015.08.087","volume":"25","author":"GE Mullen","year":"2015","unstructured":"Mullen GE, Yet L. Progress in the development of fatty acid synthase inhibitors as anticancer targets. Bioorg Med Chem Lett. 2015;25:4363\u20139.","journal-title":"Bioorg Med Chem Lett"},{"key":"8006_CR12","doi-asserted-by":"publisher","first-page":"5713","DOI":"10.1200\/JCO.2008.18.2675","volume":"26","author":"S Ogino","year":"2008","unstructured":"Ogino S, Nosho K, Meyerhardt JA, Kirkner GJ, Chan AT, Kawasaki T, et al. Cohort study of fatty acid synthase expression and patient survival in colon cancer. J Clin Oncol. 2008;26:5713\u201320.","journal-title":"J Clin Oncol"},{"key":"8006_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01962-8","volume":"23","author":"T Jiang","year":"2024","unstructured":"Jiang T, Qi J, Xue Z, Liu B, Liu J, Hu Q, et al. The m(6)A modification mediated-lncRNA POU6F2-AS1 reprograms fatty acid metabolism and facilitates the growth of colorectal cancer via upregulation of FASN. Mol cancer. 2024;23:55.","journal-title":"Mol cancer"},{"key":"8006_CR14","doi-asserted-by":"crossref","unstructured":"Xu L, Zhang Y, Lin Z, Deng X, Ren X, Huang M, et al. FASN-mediated fatty acid biosynthesis remodels immune environment in Clonorchis sinensis infection-related intrahepatic cholangiocarcinoma. J Hepatol. 2024;81:265\u201377.","DOI":"10.1016\/j.jhep.2024.03.016"},{"key":"8006_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41392-022-01099-4","volume":"7","author":"D Cao","year":"2022","unstructured":"Cao D, Yang J, Deng Y, Su M, Wang Y, Feng X, et al. Discovery of a mammalian FASN inhibitor against xenografts of non-small cell lung cancer and melanoma. Signal Transduct Target Ther. 2022;7:273.","journal-title":"Signal Transduct Target Ther"},{"key":"8006_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41318-2","volume":"14","author":"H Sun","year":"2023","unstructured":"Sun H, Zhang L, Wang Z, Gu D, Zhu M, Cai Y, et al. Single-cell transcriptome analysis indicates fatty acid metabolism-mediated metastasis and immunosuppression in male breast cancer. Nat Commun. 2023;14:5590.","journal-title":"Nat Commun"},{"key":"8006_CR17","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s43018-021-00183-y","volume":"2","author":"GB Ferraro","year":"2021","unstructured":"Ferraro GB, Ali A, Luengo A, Kodack DP, Deik A, Abbott KL, et al. Fatty acid synthesis is required for breast cancer brain metastasis. Nat Cancer. 2021;2:414\u201328.","journal-title":"Nat Cancer"},{"key":"8006_CR18","doi-asserted-by":"crossref","unstructured":"Mehta M, Raguraman R, Ramesh R, Munshi A. RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer. Adv Drug Deliv Rev. 2022;191:114569.","DOI":"10.1016\/j.addr.2022.114569"},{"key":"8006_CR19","doi-asserted-by":"crossref","unstructured":"Qin H, Ni H, Liu Y, Yuan Y, Xi T, Li X, et al. RNA-binding proteins in tumor progression. J Hematol Oncol. 2020;13:90.","DOI":"10.1186\/s13045-020-00927-w"},{"key":"8006_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.canlet.2020.09.020","volume":"496","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Li Z. RNA binding proteins: Linking mechanotransduction and tumor metastasis. Cancer Lett. 2021;496:30\u201340.","journal-title":"Cancer Lett"},{"key":"8006_CR21","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1038\/sj.onc.1201110","volume":"14","author":"F Mueller-Pillasch","year":"1997","unstructured":"Mueller-Pillasch F, Lacher U, Wallrapp C, Micha A, Zimmerhackl F, Haemister H, et al. Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene. 1997;14:2729\u201333.","journal-title":"Oncogene"},{"key":"8006_CR22","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1007\/s00018-012-1186-z","volume":"70","author":"JL Bell","year":"2013","unstructured":"Bell JL, Waechter K, Muehleck B, Pazaitis N, Koehn M, Lederer M, et al. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?. Cell Mol Life Sci. 2013;70:2657\u201375.","journal-title":"Cell Mol Life Sci"},{"key":"8006_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1066-3","volume":"18","author":"Y Li","year":"2019","unstructured":"Li Y, Xiao J, Bai J, Tian Y, Qu Y, Chen X, et al. Molecular characterization and clinical relevance of m(6)A regulators across 33 cancer types. Mol cancer. 2019;18:137.","journal-title":"Mol cancer"},{"key":"8006_CR24","doi-asserted-by":"crossref","unstructured":"Yang Z, Wang T, Wu D, Min Z, Tan J, Yu B. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer. J Exp Clin Cancer Res. 2020;39:203.","DOI":"10.1186\/s13046-020-01714-8"},{"key":"8006_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1261\/rna.1175909","volume":"15","author":"D Weidensdorfer","year":"2009","unstructured":"Weidensdorfer D, Stoehr N, Baude A, Lederer M, Koehn M, Schierhorn A, et al. Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs. RNA. 2009;15:104\u201315.","journal-title":"RNA"},{"key":"8006_CR26","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.omtn.2020.04.013","volume":"20","author":"Y Wang","year":"2020","unstructured":"Wang Y, Zhang J, Su Y, Wang C, Zhang G, Liu X, et al. miRNA-98-5p Targeting IGF2BP1 Induces Mesenchymal Stem Cell Apoptosis by Modulating PI3K\/Akt and p53 in Immune Thrombocytopenia. Mol Ther Nucleic Acids. 2020;20:764\u201376.","journal-title":"Mol Ther Nucleic Acids"},{"key":"8006_CR27","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1172\/JCI80046","volume":"126","author":"JK Palanichamy","year":"2016","unstructured":"Palanichamy JK, Tran TM, Howard JM, Contreras JR, Fernando TR, Sterne-Weiler T, et al. RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation. J Clin Investig. 2016;126:1495\u2013511.","journal-title":"J Clin Investig"},{"key":"8006_CR28","doi-asserted-by":"crossref","unstructured":"Zhou Y, Huang T, Siu HL, Wong CC, Dong Y, Wu F, et al. IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis. Mol Cancer. 2017;16:77.","DOI":"10.1186\/s12943-017-0647-2"},{"key":"8006_CR29","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1158\/0008-5472.CAN-22-3059","volume":"83","author":"Z Lin","year":"2023","unstructured":"Lin Z, Li J, Zhang J, Feng W, Lu J, Ma X, et al. Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer. Cancer Res. 2023;83:2187\u2013207.","journal-title":"Cancer Res"},{"key":"8006_CR30","doi-asserted-by":"crossref","unstructured":"Hu Y, Gong C, Li Z, Liu J, Chen Y, Huang Y, et al. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification. Mol Cancer. 2022;21:34.","DOI":"10.1186\/s12943-022-01522-y"},{"key":"8006_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216613","volume":"585","author":"J Yi","year":"2024","unstructured":"Yi J, Ma X, Ying Y, Liu Z, Tang Y, Shu X, et al. N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through the miR-128-3p\/MAPK1 axis. Cancer Lett. 2024;585:216613.","journal-title":"Cancer Lett"},{"key":"8006_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06520-0","volume":"15","author":"C Han","year":"2024","unstructured":"Han C, Hu C, Liu T, Sun Y, Hu F, He Y, et al. IGF2BP3 enhances lipid metabolism in cervical cancer by upregulating the expression of SCD. Cell Death Dis. 2024;15:138.","journal-title":"Cell Death Dis"},{"key":"8006_CR33","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10495-023-01903-8","volume":"29","author":"J Yan","year":"2024","unstructured":"Yan J, Wang X, Fan Z, Xu Y, Zhang Y, Liu Y, et al. Circ_0098823 binding with IGF2BP3 regulates DNM1L stability to promote metastasis of hepatocellular carcinoma via mitochondrial fission. Apoptosis. 2024;29:709\u201325.","journal-title":"Apoptosis"},{"key":"8006_CR34","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/cncr.35048","volume":"130","author":"Y Li","year":"2024","unstructured":"Li Y, Cao J, Wang J, Wu W, Jiang L, Sun X. Association of the m6A reader IGF2BP3 with tumor progression and brain-specific metastasis in breast cancer. Cancer. 2024;130:356\u201374.","journal-title":"Cancer"},{"key":"8006_CR35","doi-asserted-by":"crossref","unstructured":"Del Gobbo A, Morotti A, Colombo AE, Vaira V, Ercoli G, Pesenti C, et al. IMP3 expression in NSCLC brain metastases demonstrates its role as a prognostic factor in non-neuroendocrine phenotypes. Medical Oncology. 2018;35:2.","DOI":"10.1007\/s12032-017-1062-7"},{"key":"8006_CR36","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7:763\u201377.","journal-title":"Nat Rev Cancer"},{"key":"8006_CR37","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol. 2018;20:285\u201395.","journal-title":"Nat Cell Biol"},{"key":"8006_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10:93\u20135.","journal-title":"Nat Chem Biol"},{"key":"8006_CR39","doi-asserted-by":"crossref","unstructured":"Wang X, Tian L, Li Y, Wang J, Yan B, Yang L, et al. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent. J Exp Clin Cancer Res. 2021;40:80.","DOI":"10.1186\/s13046-021-01871-4"},{"key":"8006_CR40","doi-asserted-by":"crossref","unstructured":"Pan Z, Zhao R, Li B, Qi Y, Qiu W, Guo Q, et al. EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3. Molecular Cancer. 2022;21:16.","DOI":"10.1186\/s12943-021-01485-6"},{"key":"8006_CR41","doi-asserted-by":"crossref","unstructured":"Shen C, Xuan B, Yan T, Ma Y, Xu P, Tian X, et al. m6A-dependent glycolysis enhances colorectal cancer progression. Mol Cancer. 2020;19:72.","DOI":"10.1186\/s12943-020-01190-w"},{"key":"8006_CR42","doi-asserted-by":"crossref","unstructured":"Liu Z, Wang T, She Y, Wu K, Gu S, Li L, et al. N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer. 2021;20:105.","DOI":"10.1186\/s12943-021-01398-4"},{"key":"8006_CR43","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/jcmm.17093","volume":"26","author":"Y Xu","year":"2022","unstructured":"Xu Y, Guo Z, Peng H, Guo L, Wang P. IGF2BP3 promotes cell metastasis and is associated with poor patient survival in nasopharyngeal carcinoma. J Cell Mol Med. 2022;26:410\u201321.","journal-title":"J Cell Mol Med"},{"key":"8006_CR44","doi-asserted-by":"publisher","first-page":"6832","DOI":"10.18632\/oncotarget.2257","volume":"5","author":"K Taniuchi","year":"2014","unstructured":"Taniuchi K, Furihata M, Hanazaki K, Saito M, Saibara T. IGF2BP3-mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer. Oncotarget. 2014;5:6832\u201345.","journal-title":"Oncotarget"},{"key":"8006_CR45","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1023\/B:NERE.0000010461.34920.0c","volume":"29","author":"S Rainesalo","year":"2004","unstructured":"Rainesalo S, Ker\u00e4nen T, Palmio J, Peltola J, Oja SS, Saransaari P. Plasma and cerebrospinal fluid amino acids in epileptic patients. Neurochem Res. 2004;29:319\u201324.","journal-title":"Neurochem Res"},{"key":"8006_CR46","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1177\/0271678X15609331","volume":"36","author":"E Dolgodilina","year":"2016","unstructured":"Dolgodilina E, Imobersteg S, Laczko E, Welt T, Verrey F, Makrides V. Brain interstitial fluid glutamine homeostasis is controlled by blood-brain barrier SLC7A5\/LAT1 amino acid transporter. J Cereb Blood Flow Metab. 2016;36:1929\u201341.","journal-title":"J Cereb Blood Flow Metab"},{"key":"8006_CR47","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.cell.2014.11.025","volume":"159","author":"T Mashimo","year":"2014","unstructured":"Mashimo T, Pichumani K, Vemireddy V, Hatanpaa KJ, Singh DK, Sirasanagandla S, et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell. 2014;159:1603\u201314.","journal-title":"Cell"},{"key":"8006_CR48","doi-asserted-by":"publisher","first-page":"e0137204","DOI":"10.1371\/journal.pone.0137204","volume":"10","author":"YY Jung","year":"2015","unstructured":"Jung YY, Kim HM, Koo JS. Expression of lipid metabolism-related proteins in metastatic breast cancer. PLoS ONE. 2015;10:e0137204.","journal-title":"PLoS ONE"},{"key":"8006_CR49","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1016\/j.molcel.2021.08.027","volume":"81","author":"H Yoon","year":"2021","unstructured":"Yoon H, Shaw JL, Haigis MC, Greka A. Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity. Mol Cell. 2021;81:3708\u201330.","journal-title":"Mol Cell"},{"key":"8006_CR50","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ebiom.2016.12.012","volume":"16","author":"TS Heuer","year":"2017","unstructured":"Heuer TS, Ventura R, Mordec K, Lai J, Fridlib M, Buckley D, et al. FASN inhibition and taxane treatment combine to enhance anti-tumor efficacy in diverse xenograft tumor models through disruption of tubulin palmitoylation and microtubule organization and fasn inhibition-mediated effects on oncogenic signaling and gene expression. EBioMedicine. 2017;16:51\u201362.","journal-title":"EBioMedicine"},{"key":"8006_CR51","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4103\/0377-4929.97849","volume":"55","author":"ZL Liu","year":"2012","unstructured":"Liu ZL, Zhou Y, Luo QF, Hu M, Wang G, Huang SH, et al. Inhibition of fatty acid synthase supresses osteosarcoma cell invasion and migration. Indian J Pathol Microbiol. 2012;55:163\u20139.","journal-title":"Indian J Pathol Microbiol"},{"key":"8006_CR52","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.2147\/OTT.S199369","volume":"12","author":"T Lu","year":"2019","unstructured":"Lu T, Sun L, Wang Z, Zhang Y, He Z, Xu C. Fatty acid synthase enhances colorectal cancer cell proliferation and metastasis via regulating AMPK\/mTOR pathway. Oncotargets Ther. 2019;12:3339\u201347.","journal-title":"Oncotargets Ther"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08006-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08006-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08006-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:06:26Z","timestamp":1759777586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08006-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8006"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08006-z","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"8 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal procedures were approved by the Institutional Animal Care and Use Committee of Sun Yat-sen University (SYSU-IACUC-2024-000357, SYSU-IACUC-2024-000358 and SYSU-IACUC-2024-000356) and followed the Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"684"}}